Metraipolis › archive › dc_1fec588b99ee
Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation — Europe PMC PMID:40883741
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40883741
- DOI
- 10.1186/s13046-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T06:40:30.929Z
- SHA-256 of the archived text
916292de62320b258bc16b66025f25df51c6285edb2a68faa076a626aeb02d48- Stable URL of this page
https://metraipolis.com/documento/dc_1fec588b99ee
How to cite
Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation — Europe PMC PMID:40883741 — Europe PMC (en), https://europepmc.org/article/MED/40883741 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fec588b99ee (Metraipolis archive dc_1fec588b99ee, sha256 916292de62320b258bc16b66025f25df51c6285edb2a68faa076a626aeb02d48)
BibTeX
@misc{dc1fec588b99ee,
title = {Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation — Europe PMC PMID:40883741},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40883741},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fec588b99ee; sha256 916292de62320b258bc16b66025f25df51c6285edb2a68faa076a626aeb02d48},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40883741. Agents can read the archived copy with the MCP tool read_document.